Wednesday - August 01, 2018

Bayer inspires Vietnamese women to proactively protect themselves from thrush

Ho Chi Minh City, July 31, 2018 – Bayer Vietnam in collaboration with the Vietnam’s Women Union (WU) recently has organized a workshop in Ho Chi Minh City to kick-off the campaign “Gynecological disease- Diagnosis, prevention and treatment".

For many women it is not easy to talk about thrush or vaginal candidasis. Despite the fact that there are up to 75% of women experiencing the condition at least once in their lives[1], most are reticent to discuss about it and proactively seek information to protect themselves against it. In order to enable Vietnamese women to get higher awareness on taking care of their health, as well as improve their understanding of gynecological diseases, particularly thrush, Bayer Vietnam in collaboration with the Vietnam’s Women Union (WU) recently has organized a workshop in Ho Chi Minh City to kick-off the campaign “Gynecological disease- Diagnosis, prevention and treatment".

 

This is a national campaign including a series of workshops and awareness activities. To be held in major cities including Ho Chi Minh, Can Tho, Ha Noi and Da Nang, the campaign aims to convey, motivate and encourage around 100.000 Vietnamese women to overcome anxiety to proactively share their experience and seek information to proactively protect their health, in order to improve their quality of life.

 Mrs. Nguyen Thi Kieu Oanh, Deputy Director Southern region, Vietnam Women Union, representative of Vietnam Women Union, gave an opening speech for the symposium.

 

“Globally, there are three in every four women suffering from thrush at least once in their lifetime and with about 45% recurrent rate1. We want women to feel empowered and confident about their intimate health and well being. That’s why we are very excited to partner with Bayer Vietnam to help raise awareness about thrush, a condition that is very common among women. While it can be embarrassing to talk about, the collaboration on “Gynecological disease- Diagnosis, prevention and treatment" is an avenue for us to open up the conversation about thrush and helps women who may suffer from it feel less alone”, said Mrs. Nguyen Thi Kieu Oanh, Deputy Director Southern region, Vietnam Women Union, the representative of Vietnam Women Union.

 

Vietnam Women Union recognized Bayer Vietnam’s contributions to Vietnam overnment’s efforts in women’s health care.

 

Thrush is a fairly common infection that is caused by yeast called Candida albicans. Candida organisms usually live harmlessly within the vagina and these organisms are usually in a neutral state and work together with other organisms in human body. They are also kept in check by human immune system and other good bacteria. When the natural, delicate pH balance of the vagina is upset, the Candida organisms multiply and cause an itch which develops into thrush. It is not a sexually transmitted disease, people do not have to be sexually active to catch it, but the infection can pass between partners while having sex.

 

The most common symptoms of thrush include: itching or irritation of the vulva and around the vaginal opening, pain with urination, vulvar soreness or irritation, pain with intercourse, reddened and swollen vulvar and vaginal tissues. Some women have no abnormal vaginal discharge. Others have white clumpy (curd-like) or watery vaginal discharge.

  

 

 

Dr. Nguyen Thai Ha, Former Head of Medical Examination, Specialization II, Tu Du Hospital, Ho Chi Minh City gave her advice at the symposium.

 

“Women should not underestimate the first symptoms of thrush, because it may not have immediate effects on life but if left untreated, recurrent vulvovaginal candidiasis can develop. They should listen to every changein their body and actively approach doctors for advice and treatment. The duration of treatment should depend upon severity of infection. On the safe side, they should regularly have periodic health check-up. In addition, women should actively prevent thrush by practicing healthy living habits”, Dr. Nguyen Thai Ha, Former Head of Medical Examination, Specialization II, Tu Du Hospital, Ho Chi Minh City gave her advice at the workshop.

 

Treatment for thrush often includes a vaginal cream or tablet that contains the active ingredient Clotrimazole. It reduces vaginal burningitching by stopping the growth of yeast that causes the infection. Women can easily apply the cream or tablet inside the vagina at bedtime with an applicator.

  

Mr.Thai Peng Mak, Country Division Head of Consumer Health Division of Bayer in Vietnam, presented at the symposium.

 

“At Bayer, our aim is to help every consumer lead a better, healthier life through science-driven innovations that improve wellness, treat everyday ailments and prevent disease”, said Thai Peng Mak, Country Division Head of Consumer Health Division of Bayer in Vietnam. “Gynecological diseases including thrush are still a difficult topic to discuss for the women and for many healthcare providers. This partnership is an important step forward in making it more comfortable for women to share their stories in a safe environment where they will be supported and able to get care sooner. It also underlines our long-term commitment to contribute to the Government’s women heath care goals in Vietnam”, added Thai Peng Mak.

 

Overview of the symposium

 

About Bayer

 

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.com.

 

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.